US Health Division, Abt Associates Inc., Cambridge, Massachusetts, USA.
PLoS One. 2013 Jul 17;8(7):e69241. doi: 10.1371/journal.pone.0069241. Print 2013.
Abuse of prescription opioid analgesics is a serious threat to public health, resulting in rising numbers of overdose deaths and admissions to emergency departments and treatment facilities. Absent adequate patient information systems, "doctor shopping" patients can obtain multiple opioid prescriptions for nonmedical use from different unknowing physicians. Our study estimates the prevalence of doctor shopping in the US and the amounts and types of opioids involved.
The sample included records for 146.1 million opioid prescriptions dispensed during 2008 by 76% of US retail pharmacies. Prescriptions were linked to unique patients and weighted to estimate all prescriptions and patients in the nation. Finite mixture models were used to estimate different latent patient populations having different patterns of using prescribers. On average, patients in the extreme outlying population (0.7% of purchasers), presumed to be doctor shoppers, obtained 32 opioid prescriptions from 10 different prescribers. They bought 1.9% of all opioid prescriptions, constituting 4% of weighed amounts dispensed.
Our data did not provide information to make a clinical diagnosis of individuals. Very few of these patients can be classified with certainty as diverting drugs for nonmedical purposes. However, even patients with legitimate medical need for opioids who use large numbers of prescribers may signal dangerously uncoordinated care. To close the information gap that makes doctor shopping and uncoordinated care possible, states have created prescription drug monitoring programs to collect records of scheduled drugs dispensed, but the majority of physicians do not access this information. To facilitate use by busy practitioners, most monitoring programs should improve access and response time, scan prescription data to flag suspicious purchasing patterns and alert physicians and pharmacists. Physicians could also prevent doctor shopping by adopting procedures to screen new patients for their risk of abuse and to monitor patients' adherence to prescribed treatments.
滥用处方类阿片类镇痛药对公众健康构成严重威胁,导致过量用药死亡人数以及因用药过量而被送诊于急诊室和治疗机构的人数不断上升。由于缺乏充分的患者信息系统,“医生探访”患者可以从不同的、不知情的医生那里获得多种非医疗用途的阿片类药物处方。本研究评估了美国“医生探访”的普遍程度,以及涉及的阿片类药物数量和种类。
该样本包括 2008 年美国 76%的零售药店分发的 1.461 亿张阿片类药物处方的记录。这些处方与独特的患者相关联,并进行加权处理以估计全国的所有处方和患者。有限混合模型用于估计具有不同开处方者使用模式的不同潜在患者群体。平均而言,处于极端外围群体(购买者的 0.7%)的患者从 10 名不同的医生那里获得了 32 张阿片类药物处方。他们购买了所有阿片类药物处方的 1.9%,占分发量的 4%。
我们的数据没有提供可以对个人进行临床诊断的信息。这些患者中只有极少数可以肯定地被归类为出于非医疗目的而转移药物。然而,即使是那些有大量开处方者且有正当医疗需求的阿片类药物患者,也可能表明护理严重不协调。为了消除使“医生探访”和不协调护理成为可能的信息差距,各州已经创建了处方药物监测计划以收集分发的规定药物记录,但大多数医生并未访问这些信息。为了便于忙碌的从业者使用,大多数监测计划应改善访问和响应时间,扫描处方数据以标记可疑购买模式,并向医生和药剂师发出警报。医生还可以通过采用程序来筛选新患者滥用风险,并监测患者对规定治疗的依从性,从而防止“医生探访”。